# EDGAR Filing Document

**Accession Number:** 0001704292
**File Stem:** 0001704292-26-000032
**Filing Date:** 2026-4
**Character Count:** 2174
**Document Hash:** 75bc80cc47ec285332b920a09a5b1fe0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001704292-26-000032.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001704292-26-000032

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zai Lab Ltd
- **CENTRAL INDEX KEY:** 0001704292
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38205
- **FILM NUMBER:** 26903115

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 899 HALEI ROAD
- **STREET 2:** BUILDING B, PUDONG
- **CITY:** SHANGHAI
- **PROVINCE COUNTRY:** F4
- **BUSINESS PHONE:** 862161632588

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 899 HALEI ROAD
- **STREET 2:** BUILDING B, PUDONG
- **CITY:** SHANGHAI
- **PROVINCE COUNTRY:** F4

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934** 

**(Amendment No.)** 

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box: ☐

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under §240. 14a-12

**ZAI LAB LIMITED** 

**(Name of Registrant as Specified in its Charter)**

**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)** 

Payment of Filing Fee (Check the appropriate box):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

------

![zailabltd_vhxqmxregxnaxp47.jpg](zailabltd_vhxqmxregxnaxp47.jpg)

------

![zailabltd_vhxqmxregxnaxp47a.jpg](zailabltd_vhxqmxregxnaxp47a.jpg)

<br>